seed
Stage
1
Investors
About
Locke Bio provides a white‑label telehealth SaaS platform that enables e-commerce brands and businesses to launch and operate compliant online medical practices and prescription services. The product includes provider and pharmacy network integrations, LegitScript expedited approval processing, compliance features, and analytics/administration tools.
Explore Locke Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.